Current News
Country:
Operation:
Search for:
Overview Companies Countries Top News Tag Clouds
All   Business   Career   Cooperation   Finances   Laws   Manufacturing   Market
People   Politics   Products   Research   Technology

Contact | Print version | PDF version | Send article | RSS-FeedRSS-Feed

Genmab and PDL Biopharma close sale of antibody manufacturing facility

17 Mar 2008 - Genmab A/S and PDL BioPharma, Inc. announced the closing of the previously announced transaction under which Genmab has acquired PDL's antibody manufacturing facility located in Brooklyn Park, Minnesota, USA for USD 240 million in cash. The transaction was first announced on February 21, 2008.
 
Contact / Request Information
Additional information

Genmab A/S
Copenhagen, Denmark

Company
- Buyer's Guide entry of Genmab A/S
 
News
- 03 Jun 2008 - Genmab initiates Zalutumumab combination study in colorectal cancer
- 17 Apr 2008 - Novel insights into HuMax-EGFr mechanisms of action
- 05 Mar 2008 - Genmab and Pepscan to identify human antibodies against intractable targets
 more news

PDL BioPharma, Inc.
Redwood City, CA, United States of America

Company
- Buyer's Guide entry of PDL BioPharma, Inc.
 
News
- 28 Feb 2008 - Purchase Agreement Between Genmab and PDL BioPharma for Antibody Manufacturing Facility Receives Antitrust Clearance
- 25 Feb 2008 - Genmab and PDL Biopharma sign purchase agreement for antibody manufacturing facility
 

News regarding Business
MyBionity.COM
Newsletter Subscription
Your e-mail:
Top  
© 2001-2008 Chemie.DE Information Service GmbH
a Life Science Network Division

 www.Chemie.DE   www.Bionity.COM   www.ChemEurope.COM   www.ChemieKarriere.NET   www.BioKarriere.NET